New and emerging myopia management: Repeated low-level red-light therapy

Article

In a sham device-controlled, randomized, double-blind clinical trial in China, researchers utilized a device that emits 650 nm red light directly to the retina.

Image Credit: © sushytska - stock.adobe.come

Some of the challenges with lengthy outdoor time include variations in climate, proper supervision, accessibility to adequate outdoor space, and seasonal allergies. (sushytska / Adobe Stock)

In my last blog, we discussed the specifics of outdoor time as a tool to prevent or slow the onset of myopia. The most widely accepted recommendation is at least 2 hours per day of outdoor time participating in any activity that engages the child’s distance vision. Furthermore, a recent systematic review and meta-analysis revealed that increasing a child’s outdoor time by an additional 76 minutes per day reduces their risk of incident myopia by 50%.1

Although this finding is remarkable, many parents may argue that spending over 3 hours per day outdoors is a near impossible feat for their child. Some of the challenges with lengthy outdoor time include variations in climate, proper supervision, accessibility to adequate outdoor space, and seasonal allergies.

However, imagine an indoor therapy that could simulate outdoor time and potentially provide the same positive impact on myopia. This revolutionary therapy is called repeated low-level red-light (RLRL) therapy. Although not approved in the US, it is currently being widely used in China as an effective treatment for amblyopia. The idea of using it as a form of myopia control stemmed from the surprising observation of controlled axial elongation in children undergoing RLRL therapy for amblyopia.

In a sham device-controlled, randomized, double-blind clinical trial in China, researchers utilized a device that emits 650 nm red light directly to the retina. The therapy was administered at home under parent supervision 2 times per day, 5 days per week. Each session lasted 3 minutes, with the sessions separated by a minimum of 4 hours. The preliminary results of this study are promising with a significant decrease in axial elongation and myopia progression after 6 months and no structural effects on the retina. Further studies are necessary to determine the dose-response relationship, the optimal light intensity and device settings, and potential long-term side effects.2

If this treatment gets approved in the US, RLRL therapy could change the course of myopia management and provide a much more convenient approach to the recommended amount of “outdoor” time. Because of the many health benefits of true outdoor time, RLRL therapy may, perhaps, be best utilized in conjunction with true outdoor time to capitalize on both the health and myopia control benefits.

References
  1. Xiong S, Sankaridurg P, Naduvilath T, et al. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol. 2017;95(6):551-566. doi:10.1111/aos.13403
  2. Dong J, Zhu Z, Xu H, He M. Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children: A Randomized, Double-Blind, Controlled Clinical Trial. Ophthalmology. 2023;130(2):198-204. doi:10.1016/j.ophtha.2022.08.024
Recent Videos
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Optometrists reflect on their residency experiences and provide advice to current residents.
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
© 2025 MJH Life Sciences

All rights reserved.